Environmental contamination with synthetic carbon polymers, commonly referred to as plastics, has led to their detection in human tissues by chemical methods. It remains unclear whether plastics present in the body are innocuous or contribute to pathology. Building on prior observations of glossy deposits and non-biological fluorescent particles in blood vessels, the investigators set out to determine whether these objects in brain tissue represent plastics and whether they associate with microvascular features.
The team prepared plastics-enriched pellets from human brain samples and analyzed these preparations using a combination of analytical and imaging modalities. Chemical composition was assessed by pyrolysis gas-chromatography/mass spectrometry (py-GC/MS). Structural and ultrastructural content of the pellets was examined by thin-section electron microscopy (EM). For optical characterization, they used laser scanning confocal microscopy to acquire hyperspectral fluorescence profiles of plastics in suspension and compared those profiles with fluorescence observed in tissue sections.
The authors also obtained hyperspectral emission profiles from single-species industrial plastics, specifically polyethylene, polypropylene, and polystyrene, to serve as spectral references for imaging-based comparisons.
Py-GC/MS analysis of brain-derived pellets confirmed the presence of ten different plastics in these preparations. In parallel calibration experiments, a standard containing 12 plastics produced fluorescence signals for all 12 materials. Fluorescent particles were detected in every brain-derived pellet analyzed by confocal microscopy, indicating that synthetic polymers in these samples exhibit detectable autofluorescence under the imaging conditions used.
Hyperspectral profiles were obtained for individual plastics from industrial sources, including polyethylene, polypropylene, and polystyrene, establishing reference emission characteristics for single-species plastics in suspension.
In histologic sections the investigators observed abundant fluorescent particles decorating the luminal or abluminal walls of both arterioles and venules. The emission profiles of many of these particles were similar to those recorded for polyethylene and polypropylene in the calibration and single-species suspensions.
These fluorescent particles spatially coincided with the glossy deposits originally noted in white matter, supporting the interpretation that the macroscopic glossy deposits and the microscopic fluorescent particles represent the same class of materials—synthetic polymers—within brain tissue.
Several control measures were reported. Chemical analysis of the brain storage buffer used in sample handling revealed no detectable plastics, reducing the likelihood that buffer contamination accounted for the findings. Imaging controls included water-only samples and areas of slides lacking tissue, which were used to check for spurious fluorescence arising from reagents or the imaging system.
Thin-section EM was used to examine pellet contents at high resolution, providing structural context for the chemical and optical data. The combination of py-GC/MS chemical identification and hyperspectral fluorescence imaging of both standards and tissue-derived material comprised the principal validation approach.
The data indicate that certain synthetic polymers produce detectable fluorescence signatures and that particles with matching spectral properties are visible in human brain histologic sections, particularly associated with small cerebral vessels and white matter deposits. These observations open a path to investigating whether the presence, distribution, or burden of micro- and nanoplastics in brain tissue correlates with microvascular pathology or other neuropathologic changes.
The study establishes methodological groundwork—chemical confirmation by py-GC/MS combined with hyperspectral fluorescence referencing to single-species plastics—that can be applied in follow-up studies to quantify burden, refine identification by polymer type, and explore potential relationships with clinical or pathologic endpoints.
This report is a preprint and has not undergone peer review; the authors explicitly note this status. The presented summary reflects the methods and results as reported in the source. Specific quantitative metrics (for example particle counts per tissue volume, detailed polymer prevalence by tissue region, or statistical associations with clinical variables) were not reported in the abstracted content provided here. Further peer-reviewed work and expanded datasets will be required to evaluate causality between plastics presence and tissue pathology.
Funding sources declared include National Institutes of Health grants (P30AG08404, P20AG068077, F99NS139535), the Beckman Institute at Caltech, and the Harvey Family Endowment. The authors declared no competing interests.